Monday, 20 May 2019

You are here

Low-dose Bactrim Safe with Methotrexate in AAV

A high proportion of GPA patients receive pneumocystis prophylaxis, usually with TMP-SMX (Bactrim), and drug interactions are always a concern.  

Given that many GPA patients are treated with methotrexate, we often wonder – can my patient safely receive TMP-SMX prophylaxis in conjunction with methotrexate? This concern exists because both methotrexate and TMP work by inhibiting dihydrofolate reductatse and thus it is not surprising that potential for bone marrow toxicity exists. Dr. Tamaki (Japan) presented an abstract this morning looking at safety of low dose TMP-SMX (160mg-800 mg 3x/week or 80mg-400mg/day) when given with methotrexate in patients with AAV.

They performed a retrospective chart review at the Cleveland Clinic (2002-2017) and compared variables between patients receiving methotrexate both with and without TMP-SMX and found the rates of methotrexate discontinuation to be similar between both groups with no differences in reasons for discontinuation (side effect, infection, switching to another medication to treat AAV, methotrexate withdrawal after sustained remission, patient discontinued). Side effects occurred in 8.6% of the methotrexate only group and 7.1% of the methotrexate + TMP-SMX group.

This Cleveland Clinic experience reassures us that it seems safe to administer methotrexate with low dose TMP-SMX, although close monitoring of these patients is key.  

 

Add new comment

More Like This

Methotrexate Use Not Linked to Interstitial Lung Disease in RA

People with rheumatoid arthritis have a significant risk of developing interstitial lung disease (RA-ILD), yet there is often a question as to whether methotrexate (MTX) exposure can cause or worsen ILD.  A controlled cohort study suggests that MTX use is not associated with an increased risk of RA-ILD and instead, there is evidence suggesting MTX use may delay the onset of ILD.

FDA Adds Boxed Warning to Sleep Drugs

The Food and Drug Administration (FDA) added a Boxed Warning to several sleep medications (e.g., eszopiclone, zaleplon, and zolpidem), warning rare but serious injuries may occur as a result of abnormal sleep behaviors (sleepwalking, sleep driving, and engaging in other activities while not fully awake) when taking sleep medications. These complex sleep behaviors have also resulted in deaths.

Update on Vaccines in Autoimmune Patients

Although both the disease and the treatment for it in rheumatology patients may work at cross-purposes with immunizations, only a very few vaccines are absolutely contraindicated in this population, an infectious disease specialist told rheumatologists here.

RheumNowLive On Demand: Infection Prevention and Management with Newer Agents - Jack Cush, MD

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Acute Problems Associated With Cannabis Use

An observational study published in Annals of Internal Medicine finds that emergency department (ED) visits attributable to inhaled cannabis are more frequent than those attributable to edible cannabis, although the latter is associated with more acute psychiatric visits and more ED visits than expected.